P
apillomaviruses (PV) are highly species-specific DNA tumor viruses with a life cycle inseparably linked to differentiation processes in stratified epithelia. An infection of the skin with human papillomaviruses (HPV) may result in benign tumors with limited growth, which tend to regress spontaneously. However, some HPV types, called high-risk or oncogenic types, cause lesions which have a high risk for conversion to malignancy (1) . Among mucosal HPV of genus Alphapapillomavirus (alphaPV), the DNAs of HPV16 and HPV18 are frequently found integrated into the host genome in high-grade intraepithelial neoplasia and in carcinomas of the anogenital tract (2) (3) (4) . Members of the genus Betapapillomavirus (betaPVs) are part of the normal microbiological flora of the cutaneous skin, and viral infection per se does not represent the major event in skin carcinogenesis (5) . In immunosuppressed individuals and those suffering from the rare inherited disease epidermodysplasia verruciformis (EV), betaPVs (e.g., HPV5 and HPV8) are found with high viral loads and have been implicated in the development of squamous cell carcinomas (SCC) (6, 7) . Based on the observation that higher viral loads of betaPV have been found in precancerous actinic keratoses than in SCC in the general population, it has been suggested that betaPV act early in carcinogenesis and are not necessary for the maintenance of the malignant phenotype (8, 56) .
The bulge region of the hair follicle represents the natural reservoir of cutaneous PV (9, 10) , and it is thought that PV also reach stem cells of the interfollicular epidermis through microtrauma of the skin. Both E6 and E7 oncoproteins of PV have the ability to delay keratinocyte differentiation, and it is tempting to speculate that E6 and/or E7 may have the capacity to retain some infected epithelial cells in a stem cell-like state (11) , leading to disturbance of their normal proliferation and differentiation.
Human malignancies are propagated and reinitiated by a small population of cells, designated "cancer stem cells" or "tumor-initiating cells," that have the ability both to self-renew and to generate daughter cells which differentiate into the heterotypic cell populations that comprise the tumor (12) (13) (14) . Cancer stem cells share several features of embryonic and adult stem cells, including signaling pathways that guide their fate (15), a slow progression through the cell cycle (16), a requirement for a niche that supports their homing and survival (17) , and a high level of radiation and drug resistance (18, 19) . Subpopulations of cells with stem celllike properties persist in cell lines derived from a range of cancers (20) (21) (22) (23) (24) . Two hypotheses have been proposed concerning the origin of cancer stem cells. One is that adult stem cells transform into malignant cells due to the accumulation of multiple mutations, and the other that differentiated cells can dedifferentiate to produce malignant stem cells (14, 25, 26) .
Despite many attempts, a universal surface marker for epithelial stem cells has not been identified, but there are common patterns of expression of some markers. For example, the immunophenotype of cancer stem cells in breast cancer is CD44 ϩ CD24 Ϫ EpCAM ϩ (epithelial cell adhesion molecule) (27) (31, 32) . In cutaneous SCC cell lines, CD44
high EpCAM high cells also marked the epithelial cancer stem cell population (31) . In these cell lines, differentiation, induced by GSK3␤ inhibition, caused a reduction in the CD44
high EpCAM high population, a shift toward CD44 low cell surface expression, and an increase in the expression of the differentiation marker Calgranulin B (32) . EpCAM overexpression contributes to carcinogenesis by inducing anchorage-independent growth and by enhancing proliferation through upregulation of c-Myc and cyclins A and E (33, 34) . EpCAM is an essential factor in the maintenance of embryonic stem cells, activating the promoters of the pluripotencyreprogramming genes Nanog, Oct4, c-Myc, Sox2, and KLF4 (35) (36) (37) . CD44 increases cell proliferation and reprograms cancer cells to a cancer stem cell phenotype, and such cells have been identified in vitro by high cell surface expression of CD44 (CD44 high ) (20, 21, 24, 31) and characterized as holoclones by colony morphology (consisting of small, tightly packed cells corresponding to stem cells), in contrast to meroclones (transient amplifying cells) and paraclones (terminally differentiating, CD44 low cells) (21, 22) . We hypothesized that the number of cells with stem cell properties present in the early stages of skin tumor development is increased by betaPV and that an increased number of stem cells predisposes to a greater frequency and permanency of transformed cells. To investigate this hypothesis, we assessed monolayer cell cultures for effects of HPV (i) on the functional stem cell properties of clonogenicity and sphere formation and (ii) on the expression of CD44 and EpCAM cell surface markers. EpCAM expression was also determined in organotypic skin cultures and in clinical samples from EV patients.
MATERIALS AND METHODS
Cell culture and patient material. The PM1 cell line (38) Ϫ10 M cholera toxin, 5 g/ml transferrin, 2 ϫ 10 Ϫ11 M liothyronine, 5 g/ml insulin, 10 ng/ml epidermal growth factor, 1ϫ penicillin-streptomycin mixture). The cell line was cultivated at 37°C and 6% CO 2 . Pooled primary human keratinocytes from several healthy donors were purchased from Lonza (Cologne, Germany) and cultured in KGM-Gold medium (Lonza). Organotypic skin cultures were generated as described elsewhere (39, 40) . EV patients from whom skin lesions were collected (1 each of proliferative keratosis, seborrheic keratosis, and keratotic lesions and 4 SCC) have been described previously (6, 41, 42) .
Retroviral expression vectors and infection of keratinocytes. We have previously described the generation of the pLXSN-based retroviral vectors coding for HPV8 E2 (43), E6 (44), or E7 (45) . The construction of pLXSN-HPV4-E7, pLXSN-HPV5-E7, pLXSN-HPV16-E7, and pLXSN-HPV20-E7 is described in Westphal et al. (40) . For retroviral infection, 1 ϫ 10 5 cells were seeded into 6-cm dishes and treated as described in Akgül et al. (45) . Selection of infected cells was started 2 days later using G418. Positive clones were pooled and expanded.
FACS analysis and cell sorting. For fluorescence-activated cell sorter (FACS) analysis and cell sorting, cells were detached from cell culture flasks using enzyme-free, phosphate-buffered saline (PBS)-based cell dissociation buffer (Invitrogen, Darmstadt, Germany) and directly stained with anti-CD44 antibody (1:100 anti-CD44-phycoerythrin [PE]; BD Biosciences, Oxford, United Kingdom) and/or anti-EpCAM antibody (1: 100 anti-EpCAM-allophycocyanin [APC]; Miltenyi Biotec, Bergisch Gladbach, Germany) and DAPI (4=,6=-diamidino-2-phenylindole) or 7-AAD (7-amino-actinomycin D; BioLegend, San Diego, CA) for 30 min in the dark. Prior to staining with the Calgranulin B antibody (1:100 anti-Calgranulin B, clone MRP1H9; Santa Cruz, Heidelberg, Germany) and the respective secondary antibody, cells were fixed with 4% paraformaldehyde for 15 min and permeabilized with 0.5% Triton X-100 for 15 min. Before cell sorting, cells were filtered through a 30-m filter (Miltenyi Biotec). Cell analysis was performed using a FACSCanto II (BD Biosciences) or MACSQuant analyzer (Miltenyi Biotec), and cell sorting was performed using a FACSAria (BD Biosciences).
Colony formation and sphere assays. For colony formation assays, 1 ϫ 10 3 cells were seeded in 5 ml medium in 25-cm 2 culture flasks for 7 to 10 days. The cells were fixed with paraformaldehyde and stained with crystal violet (Sigma, Steinheim, Germany). For tumor sphere assays, 1 ϫ 10 3 cells were resuspended in 0.5 ml medium containing 1% methylcellulose (Sigma). Cells were plated in 48-well plates precoated with a layer of poly(2-hydroxyethyl methacrylate) and left to grow for 2 weeks.
RNA isolation, RT, and real-time PCR. To quantify mRNA levels of cellular genes, quantitative reverse transcription (qRT)-PCR using the LightCycler system (Roche, Mannheim, Germany) was performed as described previously (46, 47) . Briefly, total cellular RNA was isolated with the RNeasy kit (Qiagen, Hilden, Germany) and DNase digestion was performed on a column using RNase-free DNase. One microgram of RNA was reverse transcribed using an Omniscript kit (Qiagen) with 1 M oligo(dT) 23 primer, 10 M random nonamers, and 10 units RNase inhibitor. Two microliters of cDNA diluted 1:10 were used in a total volume of 20 l per PCR. Samples were analyzed in duplicate, together with a plasmid comprising the respective gene fragment which was used to generate a standard curve. Mean values were normalized to the hypoxanthine phosphoribosyltransferase 1 (HPRT1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels. The primer sequences for the pluripotency-reprogramming genes Nanog, Oct4, c-myc, SOX2, and KLF4 and the housekeeping genes HPRT1 and GAPDH have been described previously (46, 48, 49) .
Immunofluorescence staining of skin samples. Formalin-fixed, paraffin-embedded sections were deparaffinized by washing in 100% xylene and rehydrated through washing in decreasing concentrations of ethanol. For histological examination, sections were stained with hematoxylin and eosin. For immunohistochemistry, sections were treated with 0.1% pepsin (in 0.2 M HCl) for 10 min at 37°C and then blocked with 20% FCS for 60 min. Sections of organotypic skin cultures were incubated with primary antibody against EpCAM (mouse monoclonal VU1D9, 1:300 dilution in 2% FCS; Cell Signaling, Frankfurt, Germany). Sections of EV lesions were costained with an antibody against EpCAM and a rabbit anti-HPV8 E4 antibody raised against a glutathione S-transferase (GST)-E1^E4 fusion protein (41) overnight at 4°C. As is generally the case with E4 polyclonals, antibodies raised against the HPV8 E1^E4 protein react with the E4 proteins of related HPV types, including HPV5, -14, and -20. After extensive washes, sections were incubated with anti-mouse secondary antibody conjugated with Alexa Fluor 488 (1:500 dilution in 2% FCS; Invitrogen) and anti-rabbit secondary antibody conjugated with Alexa Fluor 594 (1:500 dilution in 2% FCS; Invitrogen) for 1 h at room temperature. After counterstaining with DAPI, staining was visualized using a Zeiss microscope and imaging software.
RESULTS

HPV8 E7 strongly increases the clonogenic activity of PM1 cells.
In order to study the clonogenic and tumorigenic activities of HPV8 oncoproteins, colony formation and sphere assays were performed using cells of the PM1 cell line, which was isolated from a premalignant skin lesion of the forehead of an immunosuppressed patient. PM1 cells are spontaneously immortalized noninvasive cells that retain the morphology and keratin expression profile of normal cultured keratinocytes and are HPV negative (38) . Colony formation assays revealed a 1.3-fold increase in the number of colonies in HPV8 E2-expressing cultures, a 1.7-fold increase in HPV8 E6-expressing cultures, and a 1.9-fold increase in HPV8 E7-expressing cultures (Fig. 1A and B) . Tumor sphereforming cells are considered a surrogate for tumor stem cells and show anchorage-independent growth, self-renewal, and high tumorigenicity (50, 51) . In nonadherent-sphere assays, HPV8 E2-and HPV8 E6-expressing cultures produced almost twice as many spheres as control cultures and, strikingly, the HPV8 E7-expressing cultures generated 4 times more spheres, which were also larger ( Fig. 1C and D ). These observations demonstrate a considerable increase in the number of cells with stem cell-like behavior in HPV8 E7-expressing cultures and a moderate increase in cultures expressing HPV8 E2 and HPV8 E6. To test whether the increase in stem cell-like cells in the HPV8 E7-expressing culture was associated with increased expression of pluripotency-reprogramming genes, qRT-PCR for c-myc, Oct4, Sox2, Nanog, and KLF4 was performed. Nanog was not expressed in PM1 cells, and KLF4 was not altered in the presence of HPV8 E7 (data not shown). However, the expression of HPV8 E7 led to 1.5-to 2.5-fold increases of c-myc, Oct4, and Sox2 gene expression (Fig. 1E) .
PM1 cells expressing high levels of CD44 or EpCAM show enhanced clonogenic activity. To assess whether CD44 and EpCAM are also useful markers in the nontransformed cutaneous keratinocyte line PM1 to probe for subpopulations of keratinocytes with stem cell-like characteristics, cells were retrovirally transduced with the empty vector pLXSN and sorted for cells expressing high or low levels of CD44 or EpCAM. For this experiment, the 5% of cells showing the weakest or strongest expression for CD44 and EpCAM were sorted from the total population and plated at low density to characterize their ability to form colonies. As shown by the results in Fig. 2, CD44 high and EpCAM high cell populations generated significantly more colonies than CD44 low and EpCAM low subpopulations. These data indicated that higher CD44 and EpCAM expression correlates with colony-forming capacity in the cutaneous keratinocyte line PM1.
HPV8 oncogenes affect CD44 and EpCAM expression in PM1 cells. To test whether the expression of HPV8 oncogenes in PM1 cells modifies the expression of CD44 or EpCAM, we characterized HPV8 E2-, E6-, or E7-expressing cells for cell surface expression of these markers. The change in the number of cells with low or high surface expression levels of CD44 or EpCAM in oncogene-positive cell lines was compared to the median expression level for control cells. The three oncogene-positive cell lines each showed a reduction in the number of cells with low CD44 expression. In HPV8 E2-, E6-, and E7-expressing cultures, the CD44 low fraction decreased about 22% compared to this fraction in the control (Fig. 3A) . The cell population with a low EpCAM expression present in the control cells was reduced by E2 expression (Fig. 3B, graph ), but the median expression level of EpCAM in the total E2-expressing culture was not altered (Fig. 3B, table) . The expression of E6 led to a 25% increase and the expression of E7 to a 43% increase in the median expression level of EpCAM compared to its expression in the control culture (Fig. 3B) . CD44 high EpCAM high cells showing stem cell-like properties are increased by HPV8 E7. To characterize the oncogenic function of HPV8 E7 cells with low and high levels of EpCAM in combination with low and high levels of CD44, we used FACS to sort for these four populations and performed colony formation and sphere assays. HPV8 E7 cells with CD44 low EpCAM low and CD44 low EpCAM high immunophenotypes produced the fewest colonies and spheres ( Fig. 4A and B, bottom) . Both the CD44 high EpCAM low and CD44 high EpCAM high cell fractions produced large numbers of colonies and spheres ( Fig. 4A and B, top) . The largestsized colonies and spheres were found within the CD44 high EpCAM low fraction (Fig. 4A and B, top left) . The CD44
high EpCAM high cell fraction was found to be significantly increased in HPV8 E7-expressing cultures (Fig. 5A) and also in PM1 cultures expressing E7 of HPV5 and HPV20 (both members of species Betapapillomavirus 1). The expression of HPV4 E7 (genus Gammapapillomavirus), however, did not change the number of CD44
high EpCAM high cells but did lead to an increase of CD44 low EpCAM low cells (Fig. 5B) . To confirm the findings for HPV8 E7 obtained using the immortalized keratinocyte line PM1, we also tested the effects of the expression of HPV8 E6 and E7 oncoproteins on CD44 and EpCAM in a pool of primary human skin keratinocytes of several healthy donors. In these cells, an increase in the CD44
high EpCAM high population due to HPV8 E7 and E6E7 expression was found (Fig. 5C ). HPV8 E6 alone, however, induced a shift of the cell population from CD44 low EpCAM low (41% with pLXSN and 24% with E6) to CD44 high EpCAM low (12% with pLXSN and 32% with E6). The shifting toward higher CD44 cell surface expression and the resulting reduction in the number of terminally differentiating CD44 low cells in the corresponding cell lines suggested an interference of HPV8 oncoproteins with keratinocyte differentiation. The expression of HPV8 E6, E7, or E6E7 caused a decrease in the percentage of cells expressing high levels of the epithelial differentiation marker Calgranulin B, indicating that HPV8 oncoproteins, besides upregulating epithelial stem cell markers, simultaneously suppress the entry of primary keratinocytes into differentiation (Fig. 5D) .
Expression of EpCAM in organotypic skin cultures of HPV E7-expressing cells and skin lesions of EV patients. To confirm EpCAM induction by E7, we analyzed its levels in organotypic skin cultures of E7-positive primary skin keratinocytes by immunofluorescence staining. After 14 days in the air-liquid interface, conditions that induce epidermal differentiation, the cultures were paraffin embedded and 4-m sections were stained. As shown by the results in Fig. 6 , EpCAM induction was not detected in HPV4 E7-expressing epithelia but was present in the suprabasal cell layers of epithelia expressing HPV5 E7 and HPV8 E7, as well as E7 of HPV16 (genus Alphapapillomavirus). These data indicate that EpCAM is induced in suprabasal keratinocytes expressing E7 of oncogenic alpha and beta HPV types but not by the wart-associated type HPV4. Finally, using clinical skin samples, we found EpCAM induction localized with a band-like appearance in the most-superficial cell layers of dysplastic EV skin (2/2) (Fig. 6a, b , and d), where betaPV positivity was identified by staining for the viral E4 protein (Fig. 6c and d) . Increased expression of EpCAM in a punctuated pattern was found in E4-positive areas of 4/4 EV SCCs and in one proliferative keratosis (images representative for EV SCC are shown in Fig. 6e to g ). However, E4-positive EpCAMnegative areas were also present (data not shown).
DISCUSSION
We have been able to demonstrate, using in vitro colony formation and tumor sphere assays, that HPV8 E7-expressing keratinocytes and, to a lesser extent, HPV8 E2-or E6-positive cells, show greater clonogenicity and ability for sphere formation. The expression of HPV8 E7 was also accompanied by an increase in transcription of the pluripotency-reprogramming genes c-myc, Oct-4, and Sox2, indicating a shift toward maintenance of stemness. CD44 and EpCAM, molecules previously shown to be expressed on stem cells in both normal and malignant epithelial tissues (31, 52, 53) , are both expressed by cells of the cutaneous keratinocyte line PM1. In this line, the CD44 high or EpCAM high cell population generated more colonies and spheres than the CD44 low or EpCAM low fraction. The expression of HPV8 E2, E6, and E7 led to a shift of the total population from low toward higher CD44 or EpCAM cell surface expression and, in turn, pointed to a reduction in the number of terminally differentiated cells. The reduction of the epithelial differentiation marker Calgranulin B in HPV8 E6-, E7-, and E6E7-expressing primary keratinocytes confirmed this assumption and revealed a blockage of the commitment of cells to differentiation. HPV8 oncogene-expressing PM1 lines, especially E7-positive ones, contained a greater number of cells with behavioral characteristics typical of stem cells and, by cell sorting, this behavior was shown to correlate with a CD44 high EpCAM high or CD44 high EpCAM low immunophenotype. This phenotype was not limited only to HPV8 E7 but could also be found on cells expressing E7 of the betaPV types HPV5 or HPV20, which are both, like HPV8, members of species Betapapillomavirus 1. A recent study of the oral cancer cell line CA1 has shown that CD44
high EpCAM high cells represent a population of proliferative cancer stem cells (31) . The significant increase found in the number of CD44 high EpCAM high cells suggests that HPV8 E7 enlarges this population of proliferative stem cell-like cells. In this context, it is worth mentioning that HPV8 E7, but not HPV8 E2 or E6, induced hyperproliferation and invasion of primary human adult keratinocytes in organotypic skin cultures (45, 54) .
Upregulation of EpCAM in organotypic skin cultures was found in the suprabasal layers of differentiating keratinocytes expressing E7 of HPV5, HPV8, and HPV16 but not in cultures ex-pressing HPV4 E7. Based on these findings, it may be hypothesized that the overexpression of EpCAM is associated only with oncogenic HPV types. During the betaPV life cycle in a productive EV lesion, small amounts of E7 transcript were detected in basal and suprabasal signals, with the highest signals in the most-superficial layers (55) . This E7 expression pattern correlates with regions of enhanced EpCAM protein levels found in dysplastic EV lesions and may indicate the generation of virus-induced transformed cells in suprabasal layers. Cells with strong EpCAM expression were also found in virus-positive areas of EV SCCs and may have contributed to betaPV-mediated carcinogenic processes in these patients.
Taken together, our findings lead to the conclusion that the expression of betaPV inhibits the entry of keratinocytes into differentiation and that the maintenance of basal cells in an undifferentiated state may increase the pool of cells available for the accumulation of damage that can persist and lead to the generation of stem cells with malignant properties.
